FdaApplication

NDA 018647

Back to search

Identifiers

Properties

PropertyValue
applicant_nameKING PHARMACEUTICALS LLC
application_typeNDA
approval_date1983-05-25

Products (2)

ProductActive ingredientStrengthDosage form
CORZIDEBENDROFLUMETHIAZIDE; NADOLOL5MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
CORZIDEBENDROFLUMETHIAZIDE; NADOLOL5MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

2 products